AbstractObjective The investigate the roles and significance of HIF-1α and CYPJ in tongue squamous cell carcinoma cell (TSCC), and further evaluate the regulatory effect of hyperthermia (HT) on HIF-1α and CYPJ in TSCC cells. Methods Eighty samples of cancer tissues and adjacent normal tissues from TSCC patients were collected. The expression levels of HIF-1α and CYPJ were detected by immunohistochemistry, Western blotting (WB) and fluorescence quantitative PCR, and the relationship between the expression levels of HIF-1α and CYPJ and clinicopathological characteristics was further analyzed. The expression levels of HIF-1α and CYPJ in Cal-27 cells under normoxic and hypoxic conditions for 24h when combined with HT (42℃), chemotherapy and both were detected by qPCR and WB. Cell migration was detected by cell scratch test and cell apoptosis was measured by flow cytometry. Results The expression levels of HIF-1α and CYPJ proteins in the tumor tissues of TSCC patients were higher than those in the adjacent normal tissues, which were significantly correlated with tumor size, TNM stage, differentiation degree and lymph node metastasis in TSCC patients (all P<0.05), whereas they were not correlated with gender or age (all P>0.05). The expression levels of HIF-1α and CYPJ in Cal-27 cells were significantly up-regulated in the hypoxic microenvironment (both P<0.05), which were also significantly enhanced by hyperthermia alone (both P<0.05). Compared with hyperthermia or chemotherapy alone, hyperthermia combined with chemotherapy significantly inhibited the expression of HIF-1α and CYPJ, suppressed cell migration and promoted cell apoptosis (all P<0.05). Conclusion s HIF-1α and CYPJ may be potential biomarkers for TSCC tumorigenicity and prognosis. In addition, tumor recurrence after hyperthermia may be due to the role of hyperthermia in triggering HIF-1α expression, which promotes the growth and survival of tumor cells adaptive to hyperthermia treatment by activating the downstream target genes, while hyperthermia combined with chemotherapy may be a promising treatment for TSCC.
Corresponding Authors:
Wang Shengzhi,Email:Wangsz916@163.com
Cite this article:
Shi Fan,Sun Qiaozhen,Zhou Xuexiao et al. Hyperthermia combined with chemotherapy induce tongue squamous cell carcinoma cell apoptosis by down-regulating HIF-1α and CYPJ expression[J]. Chinese Journal of Radiation Oncology, 2021, 30(3): 283-288.
Shi Fan,Sun Qiaozhen,Zhou Xuexiao et al. Hyperthermia combined with chemotherapy induce tongue squamous cell carcinoma cell apoptosis by down-regulating HIF-1α and CYPJ expression[J]. Chinese Journal of Radiation Oncology, 2021, 30(3): 283-288.
[1] Pezzuto A,Carico E.Role of HIF-1 in cancer progression:novel insights.A review[J].Curr Mol Med,2018,18(6):343-351.DOI:10.2174/1566524018666181109121849. [2] Rajoria S,Hanly E,Nicolini A,et al.Interlinking of hypoxia and estrogen in thyroid cancer progression[J].Curr Med Chem,2014,21(11):1351-1360.DOI:10.2174/0929867321666131201142434. [3] Zhang H,Chen J,Liu F,et al.CypA,a gene downstream of HIF-1α,promotes the development of PDAC[J].PLoS One,2014,9(3):e92824.DOI:10.1371/journal.pone.0092824. [4] Huang LL,Zhao XM,Huang CQ,et al.Structure of recombinant human cyclophilin J,a novel member of the cyclophilin family[J].Acta Crystallogr D Biol Crystallogr,2005,61(Pt 3):316-321.DOI:10.1107/S0907444904033189. [5] Oeia AL,Vriend LEM,Krawczyk PM,et al.Targeting therapy-resistant cancer stem cells by hyperthermia[J].Int J Hyperthermia,2017,33(4):419-427.DOI:10.1080/02656736.2017.1279757. [6] Wan J,Wu W.Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways[J].J Exper Clin Cancer Res,2016,35(1):119.DOI:10.1186/s13046-016-0399-7. [7] Nigro P,Pompilio G,Capogrossi MC.Cyclophilin A:a key player for human disease[J].Cell Death Dis,2013,4(10):e888.DOI:10.1038/cddis.2013.410. [8] Chen J,Liefke R,Jiang L,et al.Biochemical features of recombinant human cyclophilin J[J].Anticancer Res,2016,36(3):1175-1180. [9] Zhao X,Xia C,Wang X,et al.Cyclophilin J PPIase inhibitors derived from 2,3-quinoxaline-6 amine exhibit antitumor activity[J].Front Pharmacol,2018,9:126.DOI:10.3389/fphar.2018.00126. [10] Sinnberg T,Noor S,Venturelli S,et al.The ROS-induced cytotoxicity of ascorbate is attenuated by hypoxia and HIF-1alpha in the NCI60 cancer cell lines[J].J Cell Mol Med,2014,18(3):530-541.DOI:10.1111/jcmm.12207. [11] Dou JP,Zhou QF,Liang P,et al.Advances in nanostructure-mediated hyperthermia in tumor therapies[J].Cur Drug Metab,2018,19(2):85-93.DOI:10.2174/1389200219666180129141757. [12] Zhang QL,Cui BR,Li HY,et al.MAPK and PI3K pathways regulate hypoxia-induced atrial natriuretic peptide secretion by controlling HIF-1 alpha expression in beating rabbit atria[J].Biochem Biophys Res Commun,2013,438(3):507-512.DOI:10.1016/j.bbrc.2013.07.106. [13] Belaiba RS,Bonello S,Zähringer C,et al.Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor KappaB in pulmonary artery smooth muscle cells[J].Mol Biol Cell,2007,18(12):4691-4697.DOI:10.1091/mbc.e07-04-0391. [14] Lei T,Fernandez-Fernandez A,Manchanda R,et al.Near-infrared dye loaded polymeric nanoparticles for cancer imaging and therapy and cellular response after laser-induced heating[J].Beilstein J Nanotechnol,2014,5:313-322.DOI:10.3762/bjnano.5.35. [15] Wang L,Jiang M,Duan D,et al.Hyperthermia-conditioned OECs serum-free-conditioned medium induce NSC differentiation into neuron more efficiently by the upregulation of HIF-1 alpha and binding activity[J].Transplantation,2014,97(12):1225-1232.DOI:10.1097/TP.0000000000000118. [16] Moon EJ,Sonveaux P,Porporato PE,et al.NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1(HIF-1) via the ERK pathway after hyperthermia treatment[J].Proc Natl Acad Sci USA,2010,107(47):20477-20482.DOI:10.1073/pnas.1006646107. [17] Takahashi M,Suzuki S,Ishikawa K.Cyclophilin A-EMMPRIN interaction induces invasion of head and neck squamous cell carcinoma[J].Oncol Rep,2012,27(1):198-203.DOI:10.3892/or.2011.1474.
2021, Vol. 30 
